연구동향 분석

Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes

조은아 S M Bakhtiar Ul Islam Fen Jiang 박주은 이보라 김남득 황태호 2020년

논문상세정보
인용/피인용
' Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Interferon 1
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1 0

0.0%

' Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes' 의 참고문헌

  • Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer
    Patel MR [2015]
  • Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer : a phase I trial
    Park BH [2008]
  • Tumor restrictions to oncolytic virus
  • Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculature
    Spaapen RM [2014]
  • The role of thymidine kinase in cancer diseases
    Topolcan O [2008]
  • The role of human carboxylesterases in drug metabolism: have we overlooked their importance?
    Laizure SC [2013]
  • The formation and function of extracellular enveloped vaccinia virus
    Smith GL [2002]
  • The Role of Consolidation Chemoradiotherapy in Locally Advanced Pancreatic Cancer Receiving Chemotherapy: An Updated Systematic Review and Meta-Analysis
  • Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses
    Yang X [2014]
  • Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus
    Kirn DH [2007]
  • Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes
    McCart JA [2001]
  • Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene
    Leib DA [2000]
  • Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus
    Cho E [2018]
  • Oncolytic and immunotherapeutic vaccinia induces antibodymediated complement-dependent cancer cell lysis in humans
    Kim MK [2013]
  • NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer
    Adkins CE [2015]
  • Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice
    Qin XQ [1998]
  • Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α + dendritic cells
    Fuertes MB [2011]
  • Heating it up : oncolytic viruses make tumors 'hot' and suitable for checkpoint blockade immunotherapies
    Gujar S [2018]
  • Fighting cancer with vaccinia virus : teaching new tricks to an old dog
    Shen Y [2005]
  • Essential medicines for cancer : WHO recommendations and national priorities
    Robertson J [2016]
  • Enhanced delivery of SN-38 to human tumor xenografts with an anti-Trop-2-SN-38 antibody conjugate(Sacituzumab Govitecan)
    Sharkey RM [2015]
  • Effect of cellular location of human carboxylesterase 2 on CPT-11hydrolysis and anticancer activity
    Hsieh YT [2015]
  • Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein : effect of a point mutation in the lectin homology domain of the A34R gene
    Blasco R [1993]
  • Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecaninduced diarrhea : synthesis, quantitative structure-activity relationship analysis, and biological activity
    Wadkins RM [2004]
  • Direct effects of type I interferons on cells of the immune system
  • Deletion of F4L(ribonucleotide reductase)in vaccinia virus produces a selective oncolytic virus and promotes antitumor immunity with superior safety in bladder cancer models
    Potts KG [2017]
  • Crosstalk between immune cell and oncolytic vaccinia therapy enhances tumor trafficking and antitumor effects
    Sampath P [2013]
  • Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing mice
    Chu C [2014]
  • Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuclear cells is a predictive marker of the irinotecan to SN38 activation step in colorectal cancer patients
    Cecchin E [2005]
  • Carboxylesterase 2 as a determinant of response to irinotecan and neoadjuvant FOLFIRINOX therapy in pancreatic ductal adenocarcinoma
    Capello M [2015]
  • Antiproliferative properties of type I and type II interferon
    Bekisz J [2010]
  • Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation
  • A simple and sensitive LC/MS/MS assay for 7-ethyl-10-hydroxycamptothecin(SN-38)in mouse plasma and tissues : application to pharmacokinetic study of liposome entrapped SN-38(LE-SN38)
    Khan S [2005]